HRT Financial’s Aravive, Inc. Common Stock ARAV Stock Holding History

HRT Financial’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-127,062	Closed	-$160K	–	3334
2023 Q2	$160K	Buy	+127,062	New	+$206K	﹤0.01%	1898
2021 Q4	–	Sell	-26,749	Closed	-$99K	–	4320
2021 Q3	$99K	Sell	26,749 -3,088	-10%	-$13.2K	﹤0.01%	2904
2021 Q2	$178K	Buy	+29,837	New	+$158K	﹤0.01%	2433
2018 Q4	–	Sell	-2,693	Closed	-$22K	–	782
2018 Q3	$22K	Buy	2,693 +222	+9%	+$2.34K	﹤0.01%	386
2018 Q2	$30K	Buy	+2,471	New	+$25.4K	0.01%	253
2018 Q1	–	Sell	-2,730	Closed	-$36K	–	266
2017 Q4	$36K	Buy	+2,730	New	+$35.1K	0.04%	107

Other funds holding ARAV

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial's ARAV Position: Q3 2023 in Review

HRT Financial sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2023, closing a stake of 127,062 shares — an estimated $160K sold.

HRT Financial first reported a position in ARAV in Q4 2017 and held it in 6 quarters. The position peaked at $178K in Q2 2021. 33 funds tracked by Wall St. Rank hold ARAV as of Q3 2023.

HRT Financial reported no remaining Aravive, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
HRT Financial sold 127,062 Aravive, Inc. Common Stock shares in Q3 2023, an estimated $160K.
HRT Financial first reported a position in Aravive, Inc. Common Stock in Q4 2017 and held it in 6 quarters.
HRT Financial's Aravive, Inc. Common Stock position peaked at $178K in Q2 2021.
33 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.